CORCEPT THERAPEUTICS INC Peo Total Comp Amt
CORCEPT THERAPEUTICS INC (CORT) reported Peo Total Comp Amt of $15.30 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-17.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-17
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $15.30M DEF 14A · filed 2026-04-17 |
| 2024-12-31 | $9.89M DEF 14A · filed 2026-04-17 |
| 2023-12-31 | $9.34M DEF 14A · filed 2026-04-17 |
| 2022-12-31 | $7.35M DEF 14A · filed 2026-04-17 |
| 2021-12-31 | $10.98M DEF 14A · filed 2026-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |